Predictions
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
18.03.24
18.03.24
-
18.03.25
18.03.25
2.26%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
18.03.24
18.03.24
-
18.03.25
18.03.25
2.26%
28.03.24
28.03.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.16
18.03.24
18.03.24
-
18.03.25
18.03.25
-26.96%
31.03.24
31.03.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€59.00
17.03.24
17.03.24
-
17.03.25
17.03.25
24.64%
26.03.24
26.03.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
17.03.24
17.03.24
€0.30
30.11.25
30.11.25
76.96%
28.03.24
28.03.24
Could be very worthwhile Investment >20% year
Verastem Inc.
Start price
Target price
Perf. (%)
€10.20
17.03.24
17.03.24
€16.00
30.06.26
30.06.26
-8.82%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
16.03.24
16.03.24
€20.00
05.02.25
05.02.25
9.26%
25.03.24
25.03.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.16
16.03.24
16.03.24
€6.00
16.03.25
16.03.25
-29.70%
02.04.24
02.04.24
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€0.56
16.03.24
16.03.24
€6.00
05.02.25
05.02.25
21.30%
28.03.24
28.03.24
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€251.90
16.03.24
16.03.24
€120.00
16.03.25
16.03.25
-3.22%
30.03.24
30.03.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
16.03.24
16.03.24
€2.00
16.03.25
16.03.25
2.26%
30.03.24
30.03.24
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Chromadex Corp
Start price
Target price
Perf. (%)
€2.22
16.03.24
16.03.24
€4.00
16.03.25
16.03.25
53.15%
30.03.24
30.03.24
EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€4.89
16.03.24
16.03.24
€48.00
16.03.25
16.03.25
-12.06%
30.03.24
30.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€245.10
13.03.24
13.03.24
-
13.03.25
13.03.25
2.77%
17.03.24
17.03.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€62.04
13.03.24
13.03.24
-
13.03.25
13.03.25
-4.90%
16.03.24
16.03.24
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€252.10
13.03.24
13.03.24
-
13.04.24
13.04.24
-12.53%
14.04.24
14.04.24